Provided by Tiger Trade Technology Pte. Ltd.

BioCardia

1.04
+0.02001.96%
Post-market: 1.040.00000.00%16:10 EDT
Volume:52.54K
Turnover:54.54K
Market Cap:15.74M
PE:-1.41
High:1.05
Open:1.04
Low:1.03
Close:1.02
52wk High:1.80
52wk Low:0.7500
Shares:15.14M
Float Shares:12.12M
Volume Ratio:0.41
T/O Rate:0.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7393
EPS(LYR):-1.2341
ROE:-1803.19%
ROA:-134.97%
PB:5.83
PE(LYR):-0.84

Loading ...

BioCardia says FDA confirms CardiAMP HF II trial may support PMA for CardiAMP cell therapy in ischemic HFrEF

Reuters
·
Jun 05

FDA Confirms Cardiamp HF Ii May Support Premarket Approval of Cardiamp Cell Therapy for Ischemic Hfref

THOMSON REUTERS
·
Jun 05

BioCardia says Japan PMDA advice clears path for CardiAMP approval filing in ischemic heart failure

Reuters
·
May 28

BioCardia Announces Japan Pmda Record of Advice Supports Regulatory Submission for Approval of Cardiamp Cell Therapy for Ischemic Heart Failure

THOMSON REUTERS
·
May 28

BioCardia CEO Peter Altman acquires common shares worth $1,570.00

Reuters
·
May 22

BioCardia reports CardiAMP trial improves exercise tolerance in chronic myocardial ischemia patients

Reuters
·
May 21

BioCardia Announces CardiAMP Chronic Myocardial Ischemia Trial Results Presented at EuroPCR Showed Durable Improvements in Exercise Tolerance with Reduced Angina Frequency

GlobeNewswire
·
May 21

BioCardia to Participate in a Fireside Chat at the Alliance Global Partners (A.G.P) Healthcare Company Showcase

GlobeNewswire
·
May 19

BioCardia CEO Peter Altman acquires 5,700 shares valued at $5,244

Reuters
·
May 19

BioCardia Earnings Call: Progress, Promise and Cash Strain

TIPRANKS
·
May 19

BioCardia CEO Peter Altman acquires 5,100 shares for $5,202

Reuters
·
May 16

BioCardia Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 16

BioCardia Q1 EPS $(0.21) Misses $(0.17) Estimate

Benzinga Earnings
·
May 15

BioCardia, Inc. Q1 Net Income USD -2.259 Million

Reuters
·
May 15

BioCardia Q1 net loss narrows as expenses decline

Reuters
·
May 15

BioCardia Reports First Quarter 2026 Business Highlights and Financial Results

THOMSON REUTERS
·
May 15

BioCardia, Inc. Q1 Operating Income USD -2.266 Million

THOMSON REUTERS
·
May 15

BioCardia, Inc. Q1 Basic EPS USD -0.21

THOMSON REUTERS
·
May 15

BioCardia Inc expected to post a loss of 16 cents a share - Earnings Preview

Reuters
·
May 14

BioCardia schedules first-quarter earnings conference call, corporate update

Reuters
·
May 12